Bioactive oligopeptides in dermatology: Part I

Biosimilars in Dermatology: Current Situation (Part I).

The first biosimilar version of a biologic agent used to treat psoriasis (infliximab) entered the Spanish market on February 16 of this year, and more biosimilars can be expected to follow in the coming months and years. Logically, this new situation will have economic repercussions and alter prescribing patterns among dermatologists. In this article, we review regulatory issues related to the ...

PRACTICAL DERMATOLOGY Basic Concepts in Skin Biopsy . Part I

Controversies in Dermatology: Part II.

Peroxisomes in dermatology. Part II.

BACKGROUND Peroxisomes are small cellular organelles that were almost ignored for years because they were believed to play only a minor role in cellular functions. However, it is now known that peroxisomes play an important role in regulating cellular proliferation and differentiation as well as in the modulation of inflammatory mediators. In addition, peroxisomes have broad effects on the meta...

Diagnostic Immunopathology in 21 Century Dermatology Part I: Basics and Epidermal Deposits

Immunofluorescence techniques and other immunopathologic diagnostic techniques in dermatology involve the detection and localization of specific autoantibodies against various antigens within the skin. Since the 1960s when the lupus band test was utilized to diagnose lupus erythematosus, diagnostic immunopathologic techniques, when interpreted alongside clinical and histopathologic findings, ha...